failed avastin
Showing 1 - 25 of 3,082
Metastatic Cancer, Solid Tumor Trial in United States (bevacizumab, quality-of-life assessment)
Completed
- Metastatic Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
- bevacizumab
- quality-of-life assessment
-
Chicago, Illinois
- +3 more
Sep 4, 2019
Glioblastoma Multiforme, Glioblastoma, Glioma Trial in United States (VAL-083, Dianhydrogalactitol, Physician's Choice of
Terminated
- Glioblastoma Multiforme
- +4 more
- VAL-083, Dianhydrogalactitol
- +3 more
-
Los Angeles, California
- +4 more
Nov 12, 2019
Malignant Pleural Effusion Trial (bevacizumab and camrelizumab)
Not yet recruiting
- Malignant Pleural Effusion
- bevacizumab and camrelizumab
- (no location specified)
Apr 8, 2022
Healthy Male Subjects Trial in Changchun (HLX04, US-Avastin®, EU-Avastin®)
Completed
- Healthy Male Subjects
- HLX04
- +3 more
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
May 6, 2022
NSCLC Trial in Russian Federation (Bevacizumab, Paclitaxel, Carboplatin)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Bevacizumab
- +2 more
-
Arkhangel'sk, Russian Federation
- +10 more
Dec 8, 2022
Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))
Completed
- Malignant Glioma
- +2 more
- Bevacizumab
- +3 more
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022
Rectal Cancer, Lung Cancer, Ovarian Cancer Trial in Changchun (Bevacizumab injection, Bevacizumab injection(Avastin))
Completed
- Rectal Cancer
- +4 more
- Bevacizumab injection
- Bevacizumab injection(Avastin)
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Jul 25, 2022
Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma Trial (Atezolizumab Injection, Bevacizumab, Transarterial
Not yet recruiting
- Hepatocellular Carcinoma
- BCLC Stage B Hepatocellular Carcinoma
- Atezolizumab Injection
- +2 more
- (no location specified)
Mar 16, 2023
Metastatic Colorectal Cancer Trial in Beijing (Bevacizumab, Capecitabine, Irinotecan)
Completed
- Metastatic Colorectal Cancer
- Bevacizumab
- +4 more
-
Beijing, ChinaCancer Hospital & Institute, Chinese Academy of Medical Sciences
Mar 9, 2022
Acute Ischemic Stroke Trial in Beijing (Bailout angioplasty, thrombectomy alone)
Recruiting
- Acute Ischemic Stroke
- Bailout angioplasty
- thrombectomy alone
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Oct 31, 2022
Advanced Cancer Trial in Houston (Temsirolimus, Bevacizumab, Paclitaxel)
Active, not recruiting
- Advanced Cancer
- Temsirolimus
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 11, 2022
Brain Tumors by Advanced MRI
Completed
- Glioblastoma
- Avastin
- +5 more
-
Boston, MassachusettsMassachusetts general Hospital
Apr 6, 2022
Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for
Not yet recruiting
- Carcinoma
- +7 more
- XNW5004
- Pembrolizumab 25 mg/mL Solution for Injection
- (no location specified)
Aug 31, 2023
Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy Trial in Tianjin (Cadonilimab Injection, Ramucirumab
Recruiting
- Advanced Hepatocellular Carcinoma That Has Failed at Systemic Therapy
- Cadonilimab Injection
- Ramucirumab Injection
-
Tianjin, Tianjin, ChinaTianjin Cancer Hospital Airport Hospital
May 14, 2023
Glaucoma Trial in Cincinnati (iStent Infinite)
Recruiting
- Glaucoma
- iStent Infinite
-
Cincinnati, OhioGlaukos Investigator Site
Sep 26, 2023
Solid Tumors Trial in Guangzhou (MASCT-I injection)
Completed
- Solid Tumors
- MASCT-I injection
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 25, 2023
Healthy Trial in Zuidlaren (MYL-1402O, US marketed Avastin(R), EU marketed Avastin(R))
Completed
- Healthy
- MYL-1402O
- +2 more
-
Zuidlaren, NetherlandsPRA Health Sciences - Early Development Services
Mar 9, 2022